Charles Schwab Investment Management Inc Immunome Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Immunome Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 640,249 shares of IMNM stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
640,249
Previous 614,387
4.21%
Holding current value
$10.3 Million
Previous $4.13 Million
44.03%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMNM
# of Institutions
150Shares Held
66.6MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$133 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$78.3 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$75.3 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$72.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$65.6 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $195M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...